Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,489.40
+8.50 (0.57%)
Jan 22, 2026, 12:50 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 375.71 billion as of January 21, 2026. Its market cap has decreased by -15.09% in one year.
Market Cap
375.71B
Enterprise Value
390.34B
Revenue
93.59B
Ranking
n/a
PE Ratio
43.90
Stock Price
1,489.40
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 375.71B, an increase of 11,572.56%. That is a compound annual growth rate of 22.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 375.71B | 4.37% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mankind Pharma | 876.92B |
| Alkem Laboratories | 683.97B |
| Aurobindo Pharma | 663.10B |
| Laurus Labs | 573.71B |
| Glenmark Pharmaceuticals | 546.06B |
| Ajanta Pharma | 335.22B |
| Emcure Pharmaceuticals | 293.74B |
| Gland Pharma | 276.94B |